| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
UPPSALA, Sweden—For differential studies, improvements in LC and MS systems have allowed researchers to generate more proteomics data without the need for isotopic labeling, but this has come at the price of more complex data sets. Recently, however, researchers at GE Healthcare, Uppsala University, Karolinska Institutet, and The Informatics Factory developed an automated data analysis method to facilitate these studies.
 
As they presented in the Journal of Proteome Research, the researchers used the X! Tandem search engine and DeCyder MS to analyze data from LC-MS and LC-MS/MS experiments, looking both at absolute quantities of peptide as well as differential expression. Using spiked samples of a mixture of tryptic digests of eight proteins, they found that changes in relative ion intensities were proportional to the amount of peptide in the sample and that the analysis showed a linear response over three magnitudes (from 10 fmol/µL to 10 pmol/µL).
 
They then analyzed endogenous protein expression in brain samples from mice dosed with reserpine, a drug that induces a Parkinson's disease-like state. They found that of the 300 peptides automatically detected, 20 showed altered expression. They identified six of these peptides as arising from proenkephalin A precursor, a protein known to respond to changes in dopamine levels, the mode of action of reserpine.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue